217 related articles for article (PubMed ID: 35115382)
1. Chronic hM4Di-DREADD-Mediated Chemogenetic Inhibition of Forebrain Excitatory Neurons in Postnatal or Juvenile Life Does Not Alter Adult Mood-Related Behavior.
Tiwari P; Kapri D; Pradhan A; Balakrishnan A; Chaudhari PR; Vaidya VA
eNeuro; 2022; 9(1):. PubMed ID: 35115382
[TBL] [Abstract][Full Text] [Related]
2. Acute Chemogenetic Activation of CamKIIα-Positive Forebrain Excitatory Neurons Regulates Anxiety-Like Behaviour in Mice.
Salvi SS; Pati S; Chaudhari PR; Tiwari P; Banerjee T; Vaidya VA
Front Behav Neurosci; 2019; 13():249. PubMed ID: 31736725
[TBL] [Abstract][Full Text] [Related]
3. Chronic postnatal chemogenetic activation of forebrain excitatory neurons evokes persistent changes in mood behavior.
Pati S; Saba K; Salvi SS; Tiwari P; Chaudhari PR; Verma V; Mukhopadhyay S; Kapri D; Suryavanshi S; Clement JP; Patel AB; Vaidya VA
Elife; 2020 Sep; 9():. PubMed ID: 32955432
[TBL] [Abstract][Full Text] [Related]
4. Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome.
Wang YC; Galeffi F; Wang W; Li X; Lu L; Sheng H; Hoffmann U; Turner DA; Yang W
Exp Neurol; 2020 Apr; 326():113206. PubMed ID: 31962128
[TBL] [Abstract][Full Text] [Related]
5. [CaMKIIα-positive excitatory hippocampal neurons mediate "Zusanli" (ST36) electroacupuncture induced increase of gastric function in mice].
Liu WJ; Jiang CW; Wang H; Shen GM
Zhen Ci Yan Jiu; 2020 Nov; 45(11):861-7. PubMed ID: 33269828
[TBL] [Abstract][Full Text] [Related]
6. Chemogenetic Activation of Excitatory Neurons Alters Hippocampal Neurotransmission in a Dose-Dependent Manner.
Pati S; Salvi SS; Kallianpur M; Vaidya B; Banerjee A; Maiti S; Clement JP; Vaidya VA
eNeuro; 2019; 6(6):. PubMed ID: 31645362
[TBL] [Abstract][Full Text] [Related]
7. Chronic hM3Dq-DREADD-mediated chemogenetic activation of parvalbumin-positive inhibitory interneurons in postnatal life alters anxiety and despair-like behavior in adulthood in a task- and sex-dependent manner.
Banerjee T; Pati S; Tiwari P; Vaidya VA
J Biosci; 2022; 47():. PubMed ID: 36476774
[TBL] [Abstract][Full Text] [Related]
8. Chemogenetic Regulation of CX3CR1-Expressing Microglia Using Gi-DREADD Exerts Sex-Dependent Anti-Allodynic Effects in Mouse Models of Neuropathic Pain.
Saika F; Matsuzaki S; Kobayashi D; Ideguchi Y; Nakamura TY; Kishioka S; Kiguchi N
Front Pharmacol; 2020; 11():925. PubMed ID: 32636748
[TBL] [Abstract][Full Text] [Related]
9. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
[TBL] [Abstract][Full Text] [Related]
10. Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model.
Desloovere J; Boon P; Larsen LE; Goossens MG; Delbeke J; Carrette E; Wadman W; Vonck K; Raedt R
Neurotherapeutics; 2022 Jan; 19(1):342-351. PubMed ID: 34862591
[TBL] [Abstract][Full Text] [Related]
11. In vivo electrophysiological validation of DREADD-based modulation of pallidal neurons in the non-human primate.
Deffains M; Nguyen TH; Orignac H; Biendon N; Dovero S; Bezard E; Boraud T
Eur J Neurosci; 2021 Apr; 53(7):2192-2204. PubMed ID: 32306446
[TBL] [Abstract][Full Text] [Related]
12. Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors.
Ji B; Kaneko H; Minamimoto T; Inoue H; Takeuchi H; Kumata K; Zhang MR; Aoki I; Seki C; Ono M; Tokunaga M; Tsukamoto S; Tanabe K; Shin RM; Minamihisamatsu T; Kito S; Richmond BJ; Suhara T; Higuchi M
J Neurosci; 2016 Nov; 36(45):11544-11558. PubMed ID: 27911758
[TBL] [Abstract][Full Text] [Related]
13. Chemogenetic stimulation of the G
Kim JH; Rahman MH; Lee WH; Suk K
Pharmacol Res Perspect; 2021 Dec; 9(6):e00822. PubMed ID: 34676988
[TBL] [Abstract][Full Text] [Related]
14. Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice.
Traut J; Mengual JP; Meijer EJ; McKillop LE; Alfonsa H; Hoerder-Suabedissen A; Song SH; Fehér KD; Riemann D; Molnar Z; Akerman CJ; Vyazovskiy VV; Krone LB
Elife; 2023 Mar; 12():. PubMed ID: 36892930
[TBL] [Abstract][Full Text] [Related]
15. Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons.
Saloman JL; Scheff NN; Snyder LM; Ross SE; Davis BM; Gold MS
J Neurosci; 2016 Oct; 36(42):10769-10781. PubMed ID: 27798132
[TBL] [Abstract][Full Text] [Related]
16. Long-term chemogenetic suppression of spontaneous seizures in a mouse model for temporal lobe epilepsy.
Desloovere J; Boon P; Larsen LE; Merckx C; Goossens MG; Van den Haute C; Baekelandt V; De Bundel D; Carrette E; Delbeke J; Meurs A; Vonck K; Wadman W; Raedt R
Epilepsia; 2019 Nov; 60(11):2314-2324. PubMed ID: 31608439
[TBL] [Abstract][Full Text] [Related]
17. Does chronic systemic injection of the DREADD agonists clozapine-N-oxide or Compound 21 change behavior relevant to locomotion, exploration, anxiety, and depression in male non-DREADD-expressing mice?
Tran FH; Spears SL; Ahn KJ; Eisch AJ; Yun S
Neurosci Lett; 2020 Nov; 739():135432. PubMed ID: 33080350
[TBL] [Abstract][Full Text] [Related]
18. Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.
MacLaren DA; Browne RW; Shaw JK; Krishnan Radhakrishnan S; Khare P; España RA; Clark SD
eNeuro; 2016; 3(5):. PubMed ID: 27822508
[TBL] [Abstract][Full Text] [Related]
19. Chemogenetic manipulation of CX3CR1
Zhao S; Zheng J; Wang L; Umpierre AD; Parusel S; Xie M; Dheer A; Ayasoufi K; Johnson AJ; Richardson JR; Wu LJ
Mol Psychiatry; 2023 Jul; 28(7):2857-2871. PubMed ID: 37365239
[TBL] [Abstract][Full Text] [Related]
20. G
Marciante AB; Farmer GE; Cunningham JT
J Neurophysiol; 2020 Aug; 124(2):591-609. PubMed ID: 32697679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
